Novartis’ Ultibro Breezhaler reduces lung hyperinflation in COPD patients
admin 23rd February 2018 Uncategorised 0Treatment with Novartis’ Ultibro Breezhaler significantly boosted lung and cardiac function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation, trial findings show.
More: Novartis’ Ultibro Breezhaler reduces lung hyperinflation in COPD patients
Source: News